#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4831906	B	Inhibition of mouse Panx-1 expressed in Xenopus laevis oocytes assessed as inhibition of membrane current cells held at -60 mV and voltage steps to +60 mV in presence of CBX at 50 uM measured by Whole cell voltage clamp assay relative to control	Mus musculus	27		cell-based format	Scientific Literature
2.	ALA4831907	B	Inhibition of mouse Panx-1 expressed in Xenopus laevis oocytes assessed as inhibition of membrane current cells held at -60 mV and voltage steps to +60 mV in presence of CBX measured by Whole cell voltage clamp assay relative to control	Mus musculus	10		cell-based format	Scientific Literature
3.	ALA4831909	B	Inhibition of human P2X7R expressed in Xenopus laevis oocytes assessed as inhibition of BzATP-induced cell membrane current at 10 uM measured by Whole cell voltage clamp assay relative to control	Homo sapiens	5		cell-based format	Scientific Literature
4.	ALA4831910	B	Inhibition of wild type Cx32(E143) (unknown origin) expressed in Xenopus laevis oocytes assessed as at holding potential of -10 mV and stepped in 5 mV test pulses of 5 sec duration at 10 uM measured by Voltage clamp assay relative to control	Homo sapiens	5		cell-based format	Scientific Literature
5.	ALA4831912	F	Antiallodynic activity in oxaliplatin-induced neuropathy pain IT dosed CD-1 mouse model assessed as reversal of enhancement of pain threshold by measuring minimum effective dose measured 60 to 75 mins by cold plate assay	Mus musculus	1		organism-based format	Scientific Literature
6.	ALA4831913	F	Antiallodynic activity in oxaliplatin-induced neuropathy pain CD-1 mouse model assessed as reversal of enhancement of pain threshold at 1 nmol, IT measured after 45 to 90 mins by cold plate assay	Mus musculus	1		organism-based format	Scientific Literature